Botulinum Toxin for Glabellar Rhytids: from Standardized Injections to Personalized and Long-Lasting Strategies.

Glabellar rhytids are among the most prevalent dynamic facial wrinkles and are primarily driven by the repetitive contraction of several facial muscles, including the corrugator supercilii, procerus, and depressor supercilii. Botulinum toxin type A (BoNT-A) has been the first-line treatment for dynamic glabellar wrinkles since 2002. However, conventional standardized injection protocols based on fixed points and doses fail to accommodate individual anatomical variability or to meet the growing patient demand for personalized, long-lasting outcomes. This narrative review, informed by a structured search of PubMed and the China National Knowledge Infrastructure through July 2026, summarizes recent advances in BoNT-A treatment for glabellar rhytids, encompassing the evolution from traditional standardized strategies based on anatomy and contraction patterns (eg, 3- and 5-point techniques) to personalized and long-lasting protocols. It evaluates novel formulation technologies (eg, ready-to-use liquid botulinum toxin) and combination modalities (eg, integration with dermal fillers or surgery) and compares the potential clinical settings, rationale, limitations, safety considerations, and levels of supporting evidence across approaches. Established techniques remain effective for many patients, whereas individualized strategies and high-dose, low-volume regimens may benefit selected cases. However, the evidence base remains uneven, and several emerging techniques rely largely on anatomical rationale, observational data, or expert opinion. No formal risk-of-bias assessment or meta-analysis was performed. Treatment selection should therefore remain individualized, anatomy-informed, and grounded in shared decision making. Future studies should integrate precision medicine, intelligent technologies, and rigorous clinical research. Level of Evidence: 3 (Therapeutic) For image description, please refer to the figure legend and surrounding text.

Authors

Publication Details

Journal
PubMed
Published
2026-11-13
DOI
https://doi.org/10.1093/asj/sjag243
Primary Topic
Facial Rejuvenation and Surgery Techniques
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Botulinum Toxin for Glabellar Rhytids: from Standardized Injections to Personalized and Long-Lasting Strategies.

Yongxia Meng, Mukai Chen, Wenqi Hou, Yukun Zhao et al.
PubMed
Facial Rejuvenation and Surgery Techniques
article

Botulinum Toxin for Glabellar Rhytids: from Standardized Injections to Personalized and Long-Lasting Strategies.

Yongxia Meng, Mukai Chen, Wenqi Hou, Yukun Zhao, Ziyun Hu, Huihui Wu
article en

Abstract

Glabellar rhytids are among the most prevalent dynamic facial wrinkles and are primarily driven by the repetitive contraction of several facial muscles, including the corrugator supercilii, procerus, and depressor supercilii. Botulinum toxin type A (BoNT-A) has been the first-line treatment for dynamic glabellar wrinkles since 2002. However, conventional standardized injection protocols based on fixed points and doses fail to accommodate individual anatomical variability or to meet the growing patient demand for personalized, long-lasting outcomes. This narrative review, informed by a structured search of PubMed and the China National Knowledge Infrastructure through July 2026, summarizes recent advances in BoNT-A treatment for glabellar rhytids, encompassing the evolution from traditional standardized strategies based on anatomy and contraction patterns (eg, 3- and 5-point techniques) to personalized and long-lasting protocols. It evaluates novel formulation technologies (eg, ready-to-use liquid botulinum toxin) and combination modalities (eg, integration with dermal fillers or surgery) and compares the potential clinical settings, rationale, limitations, safety considerations, and levels of supporting evidence across approaches. Established techniques remain effective for many patients, whereas individualized strategies and high-dose, low-volume regimens may benefit selected cases. However, the evidence base remains uneven, and several emerging techniques rely largely on anatomical rationale, observational data, or expert opinion. No formal risk-of-bias assessment or meta-analysis was performed. Treatment selection should therefore remain individualized, anatomy-informed, and grounded in shared decision making. Future studies should integrate precision medicine, intelligent technologies, and rigorous clinical research. Level of Evidence: 3 (Therapeutic) For image description, please refer to the figure legend and surrounding text.

PubMed
Facial Rejuvenation and Surgery Techniques
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon